Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.190
-0.040 (-3.25%)
Jun 20, 2025, 12:48 PM - Market open

Climb Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-92.98-73.9-35.12-45.24-47.48-20.67
Upgrade
Asset Writedown & Restructuring Costs
51.6651.660.18--9.16
Upgrade
Loss (Gain) From Sale of Investments
-1.36-0.76-2.33-0.180.37-
Upgrade
Stock-Based Compensation
7.115.5612.816.993.740.71
Upgrade
Other Operating Activities
0.130.180.10.8511.47-0.36
Upgrade
Change in Accounts Payable
-1.09-1.14-0.69-0.650.32-0.02
Upgrade
Change in Other Net Operating Assets
7.362.844.450.86-4.49-2.91
Upgrade
Operating Cash Flow
-29.18-15.56-20.6-37.37-36.07-14.1
Upgrade
Cash Acquisitions
-4.65-4.65---8.28
Upgrade
Sale (Purchase) of Intangibles
------0.2
Upgrade
Investment in Securities
-167.95-111.4568.9834.44-114.97-
Upgrade
Investing Cash Flow
-177.59-121.0968.9834.44-114.978.08
Upgrade
Issuance of Common Stock
130.96130.980.84-83.29-
Upgrade
Other Financing Activities
-0.25-0.25----
Upgrade
Financing Cash Flow
130.71130.730.84-177.234.93
Upgrade
Foreign Exchange Rate Adjustments
0.050.040.3-0.410.250.36
Upgrade
Net Cash Flow
-76.01-5.8849.53-3.3426.44-0.74
Upgrade
Levered Free Cash Flow
-16.14-9.543.46-20.51-25.3-6.57
Upgrade
Unlevered Free Cash Flow
-16.14-9.543.46-20.51-25.3-6.57
Upgrade
Change in Net Working Capital
-6.13-1.78-4.07-0.716.74-0.28
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q